More prognostic information may be harvested in the subgroup analysis of esophageal adenocarcinoma unrelated death

Affiliations

¹ Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Gerontology, Tibetan Chengdu Branch Hospital of West China Hospital, Sichuan University, Chengdu, China; Department of Gerontology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.

Comment

Kai Deng et al. Gastrointest Endosc. 2022 Sep.

. 2022 Sep;96(3):566.

doi: 10.1016/j.gie.2022.04.056.

¹ Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Gerontology, Tibetan Chengdu Branch Hospital of West China Hospital, Sichuan University, Chengdu, China; Department of Gerontology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.

No abstract available

Comment in

Response.
Nieuwenhuis EA, Pouw RE. Nieuwenhuis EA, et al. Gastrointest Endosc. 2022 Sep;96(3):566-567. doi: 10.1016/j.gie.2022.05.012. Gastrointest Endosc. 2022. PMID: 35995464 No abstract available.

Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinoma.
Nieuwenhuis EA, van Munster SN, Meijer SL, Brosens LAA, Jansen M, Weusten BLAM, Alvarez Herrero L, Alkhalaf A, Schenk E, Schoon EJ, Curvers WL, Koch AD, van de Ven SEM, Verheij EPD, Nagengast WB, Westerhof J, Houben MHMG, Tang T, Bergman JJGHM, Pouw RE; Dutch Barrett Expert Centers. Nieuwenhuis EA, et al. Gastrointest Endosc. 2022 Aug;96(2):237-247.e3. doi: 10.1016/j.gie.2022.03.005. Epub 2022 Mar 12. Gastrointest Endosc. 2022. PMID: 35288149